Sign In
Buy CMPGY
$32.39
+0.120 (+0.372%)
At Close: Jun 03, 2026
Despite Fast-paced Momentum, Compass (COMP) Is Still a Bargain Stock
09:50am, Wednesday, 12'th Mar 2025
Compass (COMP) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still tradin
Compass Lexecon Adds Antitrust and Economics Expert William Rogerson
07:30am, Wednesday, 12'th Mar 2025
WASHINGTON, March 12, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that Dr. William Rogerson has affiliated with its subsidiary Compass Lexecon.
Compass Pathways to Participate in Stifel Virtual CNS Forum
06:30am, Tuesday, 11'th Mar 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
Compass Lexecon Names Mary Coleman Head of U.S. Antitrust Practice
07:30am, Monday, 10'th Mar 2025
WASHINGTON, March 10, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that Dr. Mary T. Coleman has been named Head of the U.S. Antitrust practice at its Compass Lexecon subsi
Compass Diversified Preferred C Stock: Appealing +8% Yield In A Volatile Market
08:00am, Wednesday, 05'th Mar 2025
Preferred shares, like Compass Diversified's Series C, offer income protection and higher yields, making them a strong hedge against market volatility. Compass Diversified's diversified portfolio and
Compass Lexecon Adds Healthcare Economist Matthew Grennan
07:30am, Wednesday, 05'th Mar 2025
WASHINGTON, March 05, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the continued investment in the firm's subsidiary Compass Lexecon with the appointment of Matthew Grenna
Compass Lexecon Expands Presence in Italy with Rome Office
03:30am, Tuesday, 04'th Mar 2025
ROME, March 04, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) subsidiary Compass Lexecon today announced the expansion of its presence in Italy with a new office in Rome. The office, co-he
Top Health Economics Expert Professor Jonathan Kolstad Affiliates with Compass Lexecon
07:30am, Monday, 03'rd Mar 2025
WASHINGTON, March 03, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that leading health economist Jonathan Kolstad has affiliated with its subsidiary Compass Lexecon.
Compass Pathways: Betting On The Future Of Psilocybin Therapy
05:08pm, Friday, 28'th Feb 2025
Compass Pathways is positioned to leverage regulatory tailwinds and compelling clinical data, despite broader skepticism and high cash burn in the psychedelic biotech sector. The company has a financi
Compass Lexecon Enhances Capabilities with Appointment of Prominent Economist Ginger Jin
07:30am, Friday, 28'th Feb 2025
WASHINGTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that Dr. Ginger Jin has affiliated with its subsidiary Compass Lexecon. Dr. Jin is an expert in industria
Compass Diversified Reports Fourth Quarter and Full Year 2024 Financial Results
04:15pm, Thursday, 27'th Feb 2025
WESTPORT, Conn., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market branded consumer and industrial businesses, ann
Compass Therapeutics Reports 2024 Financial Results and Provides Corporate Update
08:00am, Thursday, 27'th Feb 2025
Top-line Phase 2/3 data readout for COMPANION-002, evaluating tovecimig (CTX-009 - a DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer (BTC), is on track for the end of the firs
Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights
06:30am, Thursday, 27'th Feb 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
WASHINGTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that Dr. Daniel F. Spulber has affiliated with its subsidiary Compass Lexecon.
Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference
04:00pm, Tuesday, 25'th Feb 2025
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental heal
